Journal of the Medical Association of Thailand = Chotmaihet thangphaet · 2010
One year results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma.
Клиническое исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Thatsnarong Duangdao, Ngamchittiampai Chatuporn, Phoksunthorn Thanon
Аннотация
OBJECTIVE: To evaluate the efficacy and safety of selective laser trabeculoplasty (SLT) as a treatment of primary open angle glaucoma (POAG).
MATERIAL AND METHOD: In a prospective clinical study, 21 eyes suffering from POAG were treated with SLT over inferior 180 degrees of trabecular meshwork. The intraocular pressure (IOP) was measured before and 1 hour, 1 week, and 1, 3, 6, and 12 months after the treatment. The glaucoma medications were continued on the same regimen during the study period.
RESULTS: The mean preoperative IOP was 18.6 mmHg (SD 2.2). The mean IOP reduction were 4.9 mmHg (26.3%) 1 hour after SLT, 2.6 mmHg (14.0%) 1 week after SLT, 4.0 mmHg (21.5%) 1 month after SLT, 3.5 mmHg (18.8%) 3 months after SLT, 3.7 mmHg (19.9%) 6 months after SLT, and 3.3 mmHg (17.7%) 12 months after SLT. There were minimal adverse reactions including conjunctival injection and mild anterior chamber reaction.
CONCLUSION: SLT is a safe and effective procedure to reduce IOP in POAG patients.
MATERIAL AND METHOD: In a prospective clinical study, 21 eyes suffering from POAG were treated with SLT over inferior 180 degrees of trabecular meshwork. The intraocular pressure (IOP) was measured before and 1 hour, 1 week, and 1, 3, 6, and 12 months after the treatment. The glaucoma medications were continued on the same regimen during the study period.
RESULTS: The mean preoperative IOP was 18.6 mmHg (SD 2.2). The mean IOP reduction were 4.9 mmHg (26.3%) 1 hour after SLT, 2.6 mmHg (14.0%) 1 week after SLT, 4.0 mmHg (21.5%) 1 month after SLT, 3.5 mmHg (18.8%) 3 months after SLT, 3.7 mmHg (19.9%) 6 months after SLT, and 3.3 mmHg (17.7%) 12 months after SLT. There were minimal adverse reactions including conjunctival injection and mild anterior chamber reaction.
CONCLUSION: SLT is a safe and effective procedure to reduce IOP in POAG patients.